339 related articles for article (PubMed ID: 29425666)
1. Early Hormonal Treatment Affects Body Composition and Body Shape in Young Transgender Adolescents.
Klaver M; de Mutsert R; Wiepjes CM; Twisk JWR; den Heijer M; Rotteveel J; Klink DT
J Sex Med; 2018 Feb; 15(2):251-260. PubMed ID: 29425666
[TBL] [Abstract][Full Text] [Related]
2. Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study.
Klaver M; de Blok CJM; Wiepjes CM; Nota NM; Dekker MJHJ; de Mutsert R; Schreiner T; Fisher AD; T'Sjoen G; den Heijer M
Eur J Endocrinol; 2018 Feb; 178(2):163-171. PubMed ID: 29183889
[TBL] [Abstract][Full Text] [Related]
3. Hormonal Treatment and Cardiovascular Risk Profile in Transgender Adolescents.
Klaver M; de Mutsert R; van der Loos MATC; Wiepjes CM; Twisk JWR; den Heijer M; Rotteveel J; Klink DT
Pediatrics; 2020 Mar; 145(3):. PubMed ID: 32102929
[TBL] [Abstract][Full Text] [Related]
4. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
[TBL] [Abstract][Full Text] [Related]
5. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
[TBL] [Abstract][Full Text] [Related]
6. Relationship of total body fatness and five anthropometric indices in Chinese aged 20-40 years: different effects of age and gender.
Lei SF; Liu MY; Chen XD; Deng FY; Lv JH; Jian WX; Xu H; Tan LJ; Yang YJ; Wang YB; Xiao SM; Sun X; Jiang C; Guo YF; Guo JJ; Li YN; Liu YJ; Deng HW
Eur J Clin Nutr; 2006 Apr; 60(4):511-8. PubMed ID: 16319834
[TBL] [Abstract][Full Text] [Related]
7. Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data.
Ristori J; Cocchetti C; Castellini G; Pierdominici M; Cipriani A; Testi D; Gavazzi G; Mazzoli F; Mosconi M; Meriggiola MC; Cassioli E; Vignozzi L; Ricca V; Maggi M; Fisher AD
J Sex Med; 2020 Jan; 17(1):142-151. PubMed ID: 31735612
[TBL] [Abstract][Full Text] [Related]
8. Pubertal Suppression, Bone Mass, and Body Composition in Youth With Gender Dysphoria.
Navabi B; Tang K; Khatchadourian K; Lawson ML
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34497118
[TBL] [Abstract][Full Text] [Related]
9. Proandrogenic and Antiandrogenic Progestins in Transgender Youth: Differential Effects on Body Composition and Bone Metabolism.
Tack LJW; Craen M; Lapauw B; Goemaere S; Toye K; Kaufman JM; Vandewalle S; T'Sjoen G; Zmierczak HG; Cools M
J Clin Endocrinol Metab; 2018 Jun; 103(6):2147-2156. PubMed ID: 29672753
[TBL] [Abstract][Full Text] [Related]
10. Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen.
Fighera TM; da Silva E; Lindenau JD; Spritzer PM
Clin Endocrinol (Oxf); 2018 Jun; 88(6):856-862. PubMed ID: 29630732
[TBL] [Abstract][Full Text] [Related]
11. Gender-Affirming Hormone Treatment Induces Facial Feminization in Transwomen and Masculinization in Transmen: Quantification by 3D Scanning and Patient-Reported Outcome Measures.
Tebbens M; Nota NM; Liberton NPTJ; Meijer BA; Kreukels BPC; Forouzanfar T; Verdaasdonk RM; den Heijer M
J Sex Med; 2019 May; 16(5):746-754. PubMed ID: 30926514
[TBL] [Abstract][Full Text] [Related]
12. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
[TBL] [Abstract][Full Text] [Related]
13. Bone Mineral Density in Transgender Individuals After Gonadectomy and Long-Term Gender-Affirming Hormonal Treatment.
Dobrolińska M; van der Tuuk K; Vink P; van den Berg M; Schuringa A; Monroy-Gonzalez AG; García DV; Schultz WCMW; Slart RHJA
J Sex Med; 2019 Sep; 16(9):1469-1477. PubMed ID: 31326306
[TBL] [Abstract][Full Text] [Related]
14. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
[TBL] [Abstract][Full Text] [Related]
15. Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study.
Wiepjes CM; Vlot MC; Klaver M; Nota NM; de Blok CJ; de Jongh RT; Lips P; Heijboer AC; Fisher AD; Schreiner T; T'Sjoen G; den Heijer M
J Bone Miner Res; 2017 Jun; 32(6):1252-1260. PubMed ID: 28370342
[TBL] [Abstract][Full Text] [Related]
16. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria.
Klink D; Caris M; Heijboer A; van Trotsenburg M; Rotteveel J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E270-5. PubMed ID: 25427144
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
Lem AJ; van der Kaay DC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
[TBL] [Abstract][Full Text] [Related]
18. Dual energy X-ray absorptiometry body composition and aging in a population-based older cohort.
Shaw KA; Srikanth VK; Fryer JL; Blizzard L; Dwyer T; Venn AJ
Int J Obes (Lond); 2007 Feb; 31(2):279-84. PubMed ID: 16788568
[TBL] [Abstract][Full Text] [Related]
19. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
[TBL] [Abstract][Full Text] [Related]
20. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
